Altimmune
ALT
36 hedge funds and large institutions have $41.4M invested in Altimmune in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
71% more call options, than puts
Call options by funds: $72K | Put options by funds: $42K
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
9% more funds holding
Funds holding: 33 → 36 (+3)
21% less capital invested
Capital invested by funds: $52.6M → $41.4M (-$11.2M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.35M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$426K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$73.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$71.6K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$31.2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
26
Ladenburg Thalmann Financial Services
Miami,
Florida
| $17K | – | – | – |
|
|
AIM
27
Acrospire Investment Management
Chicago,
Illinois
| $11K | +$10.2K | +20 | New |
|
28
Group One Trading
Chicago,
Illinois
| $7K | -$1.02K | -2 | -13% |
|
29
UBS Group
Zurich,
Switzerland
| $7K | +$2.05K | +4 | +50% |
|
30
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $5K | – | – | – |
|
31
Morgan Stanley
New York
| $4K | – | – | – |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $4K | +$3.58K | +7 | New |
|
33
Citigroup
New York
| $2K | -$512 | -1 | -25% |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
35
Barclays
London,
United Kingdom
| $1K | +$2.56K | +5 | New |
|
36
Geode Capital Management
Boston,
Massachusetts
| $566 | – | – | – |
|
|
MAM
37
MPM Asset Management
Boston,
Massachusetts
| – | -$12.1M | -21,159 | Closed |
|
38
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$98K | -172 | Closed |
|
39
Goldman Sachs
New York
| – | -$32K | -57 | Closed |
|
40
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$20.5K | -40 | Closed |
|
ALT Hedge Fund Activity: Q1 2016 in Review
36 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2016, worth a combined $41.4M — down 21% from $52.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ALT positions and 4 closed out — a net gain of 3 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Hudson Bay Capital Management, adding an estimated $1.35M. The largest seller was MPM Asset Management, exiting entirely with an estimated $12.1M sold.
- 36 institutional investors held Altimmune (ALT) as of Q1 2016, up from 33 in Q4 2015.
- Funds reported $41.4M of Altimmune stock for Q1 2016, down 21% quarter-over-quarter.
- 7 funds opened new Altimmune positions in Q1 2016 and 4 closed out, a net change of +3 holders.
- The largest Altimmune buyer in Q1 2016 was Hudson Bay Capital Management, an estimated $1.35M added.
- The largest Altimmune seller in Q1 2016 was MPM Asset Management, an estimated $12.1M sold.
Based on aggregated 13F filings for Q1 2016.